CoChat

Sustained Codelivery of Cisplatin and Paclitaxel via an Injectable Prodrug Hydrogel for Ovarian Cancer Treatment

Shen, Wenjia, Chen, Xiaobin, Luan, Jiabin, Wang, Danni, Yu, Lin, Ding, Jiandong · 2017 · ACS Applied Materials & Interfaces

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Abstract

The sustained release of both the hydrophilic drug and hydrophobic drug from one delivery system remains challenging in pharmaceutics and biomaterials science. The combination of hydrophilic cisplatin and hydrophobic paclitaxel (PTX) exhibits a clinical survival advantage compared with the individual drug therapy against various tumors such as ovarian cancer. In this study, a localized, long-term codelivery system of cisplatin and PTX was developed using an injectable and thermosensitive polymer-platinum(IV) conjugate hydrogel as the carrier. The thermosensitive Bi(mPEG-PLGA)-Pt(IV) (PtGel) conjugate was synthesized via covalently linking two mPEG-PLGA copolymers onto a Pt(IV) prodrug, and its concentrated aqueous solution exhibited a reversible sol-gel transition upon heating. Meanwhile, the core-corona micelles formed by the amphiphilic conjugates in water could serve as a reservoir for the solubilization of PTX, and thus an injectable binary drug-loaded hydrogel formulation was obtained. We also found that the introduction of PTX into the conjugate hydrogel decreased its sol-gel transition temperature and improved its gel strength. In vitro release experiments showed that both of the loaded drugs were released in a sustained manner for as long as 2.5 months, which was the longest combination delivery of these two drugs ever reported. In vitro cellular assays revealed that the dual-drug system exhibited a synergistic anticancer effect against ovarian cancer cells. Finally, using the SKOV-3 ovarian cancer xenograft mouse model, we demonstrated that a single injection of the PTX-loaded conjugate hydrogel system resulted in enhanced anticancer efficacy and significantly reduced the side effects, when compared with the multiple injections of the free drug combination.

Overview

Integrity signals

Registry

Crossref · 10.1021/acsami.7b11998

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 65 references

Research works printed but not linked: 2

  1. Hayashi T., 2006, Gan to Kagaku Ryoho, 33, 1167
  2. Dash S., 2010, Acta Pol. Pharm., 67, 217

Cited by

Metadata

Authors
Shen, W., Chen, X., Luan, J., Wang, D., Yu, L., & Ding, J.
Affiliations
Fudan University (CN)
Corresponding author
Yu, Lin
Venue
ACS Applied Materials & Interfaces
Published
2017-11-13
Volume
9
Issue
46
Pages
40031-40046
ISSN
  • 1944-8244 (ISSN-L)
  • 1944-8252
OpenAlex
W2770498164
Cited by
138
References
65
Citations by year
2026: 8 · 2025: 16 · 2024: 8 · 2023: 17 · 2022: 15 · 2021: 20 · 2020: 17 · 2019: 21 · 2018: 16
FWCI
5.68
Type
journal article
Language
en
Open access
closed
Locations
  • ACS Applied Materials & Interfaces (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ministry of Science and Technology of the People's Republic of China (2016YFC1100300)
  • National Natural Science Foundation of China (21474019, 51273217)
  • Science and Technology Developing Foundation of Shanghai (15JC1490300)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
cisplatin, paclitaxel, ovarian cancer, co-delivery, injectable hydrogel, thermosensitive hydrogel, platinum(IV) prodrugs, sol-gel transition, sustained drug release, combination chemotherapy, synergistic antitumor effect, SKOV3 xenograft
MeSH terms
Animals, Cisplatin, Drug Carriers, Female, Micelles, Ovarian Neoplasms, Polyethylene Glycols, Prodrugs, Drug Delivery Systems, Paclitaxel, Hydrogels, Cell Line, Tumor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.